Profile data is unavailable for this security.
About the company
Coretag, Inc. is focused on the development of cancer imaging and targeted radiotherapy, based on its Necrosis Targeting Platform Technology (NTPT). The Company developed NTPT as a result of the discovery of a group of cyanine dyes which have selective targeting properties for intracellular proteins. These proteins become available for binding only when the cell membrane loses its integrity, which occurs once a cell has become necrotic. The Company has developed a portfolio of products that address high unmet needs in oncology. The Company develops targeted radiotherapy with 177Lu (lutetium) and 121Pb (lead) for the treatment of rapidly growing tumors and metastasis. It also develops targeted diagnostics with 89Zr (zirconium) and 111In (indium) for detecting and quantifying necrotic tissue in the human body.
- Revenue in USD (TTM)0.00
- Net income in USD-34.52k
- Incorporated2014
- Employees0.00
- LocationCoretag Inc7325 Oswego RoadLIVERPOOL 13090United StatesUSA
- Phone+1 (315) 451-7515
- Websitehttps://www.coretag.ch/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atrion Corp | 176.67m | 18.72m | 797.95m | 712.00 | 42.64 | 3.30 | 23.30 | 4.52 | 10.63 | 10.63 | 100.32 | 137.46 | 0.6794 | 1.56 | 7.93 | 248,127.80 | 7.20 | 11.96 | 7.63 | 12.62 | 33.77 | 41.99 | 10.60 | 19.05 | 3.06 | -- | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| Avanos Medical Inc | 680.10m | -1.60m | 895.13m | 3.77k | -- | 0.7316 | 20.44 | 1.32 | -0.0315 | -1.33 | 14.62 | 26.65 | 0.4005 | 1.62 | 5.48 | 180,350.00 | -0.0942 | -0.6527 | -0.1055 | -0.7338 | 56.33 | 54.45 | -0.2353 | -1.60 | 1.47 | 4.85 | 0.1257 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| BioLife Solutions Inc | 137.30m | -62.93m | 931.97m | 409.00 | -- | 2.77 | -- | 6.79 | -1.43 | -1.43 | 3.10 | 7.30 | 0.3238 | 2.17 | 5.61 | 335,687.00 | -14.84 | -13.76 | -16.52 | -15.04 | 32.97 | 36.76 | -45.84 | -42.99 | 1.77 | -32.08 | 0.0717 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Simulations Plus Inc | 64.67m | 10.52m | 936.49m | 192.00 | 90.57 | 5.29 | 63.73 | 14.48 | 0.5174 | 0.5174 | 3.18 | 8.86 | 0.3523 | -- | 4.31 | 336,812.50 | 5.73 | 7.20 | 6.07 | 7.61 | 75.14 | 77.61 | 16.26 | 21.29 | -- | -- | 0.00 | 45.70 | 10.52 | 14.96 | -20.20 | 6.02 | 12.91 | 0.8548 |
| Figs Inc | 544.71m | 22.16m | 941.36m | 354.00 | 44.67 | 2.41 | 37.08 | 1.73 | 0.1238 | 0.1238 | 3.00 | 2.29 | 1.21 | 1.10 | 118.49 | 1,538,720.00 | 4.93 | -- | 5.72 | -- | 68.56 | -- | 4.07 | -- | 3.83 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
| Owens & Minor, Inc. | 10.42bn | -38.77m | 1.01bn | 13.70k | -- | 1.13 | 4.02 | 0.0972 | -0.5099 | -0.5099 | 136.98 | 11.71 | 1.98 | 6.79 | 14.60 | 760,861.20 | -0.7372 | 1.32 | -1.11 | 2.07 | 20.75 | 16.48 | -0.3719 | 0.5614 | 0.5648 | 2.19 | 0.7065 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Artivion Inc | 368.21m | -9.58m | 1.07bn | 1.50k | -- | 3.63 | 78.56 | 2.91 | -0.2615 | -0.2615 | 8.64 | 7.07 | 0.4779 | 1.64 | 5.37 | 245,470.70 | -1.25 | -2.20 | -1.33 | -2.36 | 64.75 | 65.51 | -2.61 | -5.34 | 4.26 | 2.26 | 0.5176 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| Silk Road Medical Inc | 185.49m | -53.42m | 1.07bn | 474.00 | -- | 7.23 | -- | 5.79 | -1.37 | -1.37 | 4.76 | 3.73 | 0.7247 | 2.08 | 7.87 | 391,322.80 | -20.87 | -29.02 | -22.75 | -32.98 | 73.31 | 72.91 | -28.80 | -46.84 | 9.62 | -- | 0.34 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
| AtriCure Inc | 414.60m | -37.23m | 1.08bn | 1.20k | -- | 2.37 | -- | 2.61 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -10.27 | 0.1212 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Coretag Inc | 0.00 | -34.52k | 1.13bn | 0.00 | -- | -- | -- | -- | -0.3806 | -0.3806 | 0.00 | -0.9801 | 0.00 | -- | -- | -- | -3,303.35 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| Establishment Labs Holdings Inc | 155.79m | -82.76m | 1.18bn | 781.00 | -- | 20.64 | -- | 7.55 | -3.15 | -3.15 | 5.91 | 2.07 | 0.6095 | 0.9191 | 3.39 | 171,579.30 | -32.38 | -33.22 | -39.25 | -41.12 | 65.01 | 64.73 | -53.12 | -43.19 | 2.73 | -21.30 | 0.7715 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| Omnicell Inc | 1.10bn | -21.05m | 1.20bn | 3.65k | -- | 1.01 | 18.31 | 1.09 | -0.461 | -0.461 | 24.19 | 25.88 | 0.4863 | 5.17 | 3.86 | 302,091.50 | -0.9283 | 1.73 | -1.15 | 2.25 | 42.63 | 46.69 | -1.91 | 2.92 | 2.13 | -- | 0.3243 | 0.00 | -11.48 | 7.82 | -460.68 | -- | 0.235 | -- |
| Adapthealth Corp | 3.25bn | -695.41m | 1.32bn | 10.70k | -- | 0.9012 | -- | 0.4056 | -5.18 | -5.18 | 24.27 | 10.97 | 0.6637 | 21.66 | 8.30 | 303,555.90 | -14.15 | -4.34 | -15.82 | -4.89 | 18.45 | 18.28 | -21.32 | -6.47 | 1.11 | 2.08 | 0.6025 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Alphatec Holdings Inc | 511.63m | -191.60m | 1.38bn | 839.00 | -- | 37.54 | -- | 2.71 | -1.49 | -1.49 | 3.97 | 0.4294 | 0.7612 | 1.34 | 6.70 | 609,808.10 | -28.51 | -30.97 | -37.13 | -39.47 | 65.89 | 66.02 | -37.45 | -46.22 | 1.49 | -5.17 | 0.8938 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Inmode Ltd | 466.26m | 181.11m | 1.47bn | 581.00 | 8.27 | 1.76 | 8.11 | 3.16 | 2.11 | 2.11 | 5.42 | 9.87 | 0.5973 | 1.71 | 16.09 | 802,509.40 | 23.20 | 31.32 | 25.21 | 35.64 | 83.10 | 84.46 | 38.84 | 39.65 | 12.66 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
Data as of Jul 06 2021. Currency figures normalised to Coretag Inc's reporting currency: US Dollar USD
